Terms: = Lymphoma AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
12 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. B-Lymphoblastic Leukemia With Aberrant CD5 Expression.
Ye MT; Zhu J; Luo DX; Wang Y; Chen Z; Yang Y; Tian C; Zhang Y; You MJ
Am J Clin Pathol; 2021 Sep; 156(4):586-595. PubMed ID: 33822875
[TBL] [Abstract] [Full Text] [Related]
3. Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
Tembhare PR; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Panda D; Patkar NV; Narula G; Girase K; Verma S; Sanyal M; Sriram HN; Banavali S; Gujral S; Subramanian PG
Cytometry B Clin Cytom; 2021 Jul; 100(4):421-433. PubMed ID: 32812702
[TBL] [Abstract] [Full Text] [Related]
4. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
[TBL] [Abstract] [Full Text] [Related]
5. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
Tsitsikov E; Harris MH; Silverman LB; Sallan SE; Weinberg OK
Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
[TBL] [Abstract] [Full Text] [Related]
6. A subset of cd45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.
Kim SM; Lee ST; Ryu KJ; Kim HJ; Kim SH; Ko YH; Kim WS; Kim SJ
Leuk Lymphoma; 2015; 56(11):3052-7. PubMed ID: 25739938
[TBL] [Abstract] [Full Text] [Related]
7. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract] [Full Text] [Related]
8. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings.
Zheng G; Schmieg J; Guan H; Ali SZ
Acta Cytol; 2012; 56(2):204-8. PubMed ID: 22378086
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India.
Patkar N; Nair S; Alex AA; Parihar M; Manipadam MT; Arora N; Ahmed R; Abraham A; George B; Viswabandya A; Srivastava V; Srivastava A; Mathews V
Leuk Lymphoma; 2012 Apr; 53(4):609-15. PubMed ID: 21916832
[TBL] [Abstract] [Full Text] [Related]
10. Cytologically malignant lymphoid pericardial effusion with benign clinical outcome.
Maeder M; Spieler P; Krapf R; Diethelm M
Swiss Med Wkly; 2005 Jun; 135(25-26):377-81. PubMed ID: 16106328
[TBL] [Abstract] [Full Text] [Related]
11. cd45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia.
Suzuki M; Matsuoka H; Yamashita K; Maeda K; Kawano K; Uno H; Tsubouchi H
Leuk Lymphoma; 1998 Feb; 28(5-6):583-90. PubMed ID: 9613989
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical characteristics of Hodgkin and Reed-Sternberg cells in relation to age and clinical outcome.
Enblad G; Sundström C; Glimelius B
Histopathology; 1993 Jun; 22(6):535-41. PubMed ID: 8354486
[TBL] [Abstract] [Full Text] [Related]
